Literature DB >> 21490448

Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.

Joo Y Song1, Franziska C Eberle, Liqiang Xi, Mark Raffeld, Osama Rahma, Wyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, Elaine S Jaffe.   

Abstract

We report a case of concurrent nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and classic Hodgkin lymphoma (cHL), of nodular sclerosis subtype, in an otherwise healthy 24-year-old man with a strong family history of cHL. The patient was found to have a parotid mass, which was diagnosed as NLPHL, and a thymic mass diagnosed as cHL, of nodular sclerosis subtype concurrently. The lesion in the parotid showed features typical of NLPHL by morphology and immunophenotype. The LP cells were positive for PAX5, CD20, Oct2, weakly positive for CD30, and negative for CD15. The thymic lesion, diagnosed as cHL, of nodular sclerosis subtype, showed prominent bands of fibrosis and Hodgkin/Reed-Sternberg and lacunar cells positive for CD30 and CD15. These cells were variably positive for CD20 and negative for Oct2. PAX5 was weakly positive. Immunoglobulin gene rearrangement studies by polymerase chain reaction were carried out on microdissected Hodgkin/Reed-Sternberg and LP cells, which were shown to have identically sized peaks. NLPHL and cHL are 2 distinct diseases and are almost never seen concurrently. We present a case in which polymerase chain reaction analysis indicated that the tumor cells of these 2 distinct entities were clonally identical.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490448      PMCID: PMC3077769          DOI: 10.1097/PAS.0b013e3182147f91

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  29 in total

1.  Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma.

Authors:  Iwona Wlodarska; Michel Stul; Chris De Wolf-Peeters; Anne Hagemeijer
Journal:  Haematologica       Date:  2004-08       Impact factor: 9.941

2.  Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

3.  Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy?

Authors:  J T Sundeen; J Cossman; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1988-08       Impact factor: 6.394

4.  Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription.

Authors:  T Marafioti; M Hummel; H D Foss; H Laumen; P Korbjuhn; I Anagnostopoulos; H Lammert; G Demel; J Theil; T Wirth; H Stein
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

5.  Nodular paragranuloma can transform into high-grade malignant lymphoma of B type.

Authors:  M L Hansmann; H Stein; C Fellbaum; P K Hui; M R Parwaresch; K Lennert
Journal:  Hum Pathol       Date:  1989-12       Impact factor: 3.466

6.  Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.

Authors:  M Miettinen; K O Franssila; E Saxén
Journal:  Cancer       Date:  1983-06-15       Impact factor: 6.860

Review 7.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

8.  Nodular lymphocyte predominant Hodgkin lymphoma in siblings.

Authors:  Gavin N S Campbell; Josephine Lloyd; Andrew Wotherspoon; Carmel Coulter; Barbara J Bain
Journal:  Leuk Lymphoma       Date:  2004-03

9.  Incidence of familial Hodgkin's disease.

Authors:  L Kerzin-Storrar; M J Faed; J B MacGillivray; P G Smith
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

10.  Hodgkin's disease: case control epidemiological study in Yorkshire.

Authors:  S M Bernard; R A Cartwright; C M Darwin; I D Richards; B Roberts; C O'Brien; C C Bird
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

View more
  4 in total

Review 1.  Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.

Authors:  Taishi Takahara; Akira Satou; Toyonori Tsuzuki; Shigeo Nakamura
Journal:  Diagnostics (Basel)       Date:  2022-06-20

Review 2.  Pathobiology of hodgkin lymphoma.

Authors:  Claudio Agostinelli; Stefano Pileri
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-06-05       Impact factor: 2.576

3.  Composite t(14;18)-Negative Follicular Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

Authors:  John Patrick O'Neill; Fiona Quinn; Anita Dowling; Jan Walker; Triona Hayes; Brian Bird; Richard Flavin
Journal:  Case Rep Hematol       Date:  2018-08-02

Review 4.  The Grey Zones of Classic Hodgkin Lymphoma.

Authors:  Jan Bosch-Schips; Massimo Granai; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.